19 May 2013
Keywords: amgen, mucositis, drug, clears, phase, iii, trial
Article | 03 February 2003
Amgen's recombinant human keratinocte growth factor has been found todecrease both the duration and incidence of severe oral mucositis in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 February 2003
17 May 2013
© 2013 thepharmaletter.com